Globe and Mail examines HIV/AIDS rate in India

The Globe and Mail writes that "[w]hen India announced in 2007 that it had 2.3 million people living with HIV, rather than the 5.7 million reported the year before, the government first attributed much of the change to better data collection. Many in the AIDS field were skeptical."

Anjali Gopalan, head of India's Naz Foundation said, "We and all the other AIDS organizations think the number of people accessing services is increasing, so why are the infection numbers so low?" However, others say "more and more research points to a substantial change in sexual behaviour and with it a decline in the spread of HIV," according to the newspaper.

"'The decline is real. The numbers have plausibility and credibility,' says Prabhat Jha, an epidemiologist who directs the Centre for Global Health Research in Toronto, and was an architect of India's early AIDS-control program. 'There has been a profound change in behaviour among clients and sex workers that accounts for most of the drop,'" the Globe and Mail writes. The article examines the mass distribution of condoms, media and educational campaigns, and the status of women in India, compared to efforts and cultural norms in Africa.

Despite progress, the newspaper writes: "HIV remains of critical concern here [in India]: With 2.3-million infected people, this country has the third-largest burden of HIV-AIDS in the world, and has succeeded in getting treatment to fewer than half of the people who need it." Also, "[t]he successes achieved have been mostly in the richer south of the country." In the north, "weaker governments and health systems ... have yet to embark on serious AIDS-control programs" (Nolen, 8/31).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Affordability and supply remain critical to the success of long-lasting HIV drug